用于二级卒中预防的抗血小板/抗血栓治疗的优化。
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.
作者信息
Srivastava Padma
机构信息
Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi, India.
出版信息
Ann Indian Acad Neurol. 2010 Jan;13(1):6-13. doi: 10.4103/0972-2327.61270.
Abstract
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.
摘要
抗血小板治疗在二级卒中预防中的作用具有重大意义。目前主要使用的抗血小板药物是阿司匹林、氯吡格雷以及联合用药方案。本综述重点关注基于随机对照试验证据的抗血小板治疗方案优化、不同的抗血小板治疗方案以及每位患者可能特有的风险评估。
相似文献
1
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.用于二级卒中预防的抗血小板/抗血栓治疗的优化。
Ann Indian Acad Neurol. 2010 Jan;13(1):6-13. doi: 10.4103/0972-2327.61270.
2
Antiplatelet therapy in stroke prevention.预防中风的抗血小板治疗。
Adv Cardiol. 2012;47:141-54. doi: 10.1159/000338050. Epub 2012 Aug 9.
3
Is there a role for combinations of antiplatelet agents in stroke prevention?抗血小板药物联合应用在卒中预防中的作用如何？
Curr Treat Options Neurol. 2007 Nov;9(6):442-50. doi: 10.1007/s11940-007-0045-y.
4
New opportunities to optimize antithrombotic therapy for secondary stroke prevention.优化抗血栓治疗以预防二级卒中的新机遇。
Int J Stroke. 2019 Apr;14(3):220-222. doi: 10.1177/1747493019828548. Epub 2019 Feb 6.
5
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.缺血性卒中后氯吡格雷与阿司匹林联合抗血小板治疗：证据综述
Am J Health Syst Pharm. 2015 Oct 1;72(19):1623-9. doi: 10.2146/ajhp140804.
6
Combination antiplatelet agents for secondary prevention of ischemic stroke.用于缺血性卒中二级预防的联合抗血小板药物
Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233.
7
Antiplatelet Therapy After Noncardioembolic Stroke.非心源性卒后抗血小板治疗。
Stroke. 2019 Jul;50(7):1812-1818. doi: 10.1161/STROKEAHA.118.024497. Epub 2019 Jun 10.
8
Antiplatelet therapy and anticoagulation in patients with hypertension.高血压患者的抗血小板治疗与抗凝治疗
Am Fam Physician. 2005 Mar 1;71(5):897-9.
9
A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke.抗血小板治疗在缺血性脑卒中二级预防中的临床新进展。
Curr Cardiol Rep. 2021 Aug 19;23(10):145. doi: 10.1007/s11886-021-01581-5.
10
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.三联抗血小板治疗（阿司匹林、氯吡格雷和双嘧达莫）用于卒中二级预防的随机对照试验：安全性、耐受性和可行性
PLoS One. 2008 Aug 6;3(8):e2852. doi: 10.1371/journal.pone.0002852.
引用本文的文献
1
The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.膳食类黄酮槲皮素的代谢产物具有强大的抗血栓形成活性，并与阿司匹林相互作用以增强抗血小板作用。
TH Open. 2019 Jul 30;3(3):e244-e258. doi: 10.1055/s-0039-1694028. eCollection 2019 Jul.
2
Optimizing antiplatelet / antithrombotic therapy.优化抗血小板/抗血栓治疗。
Ann Indian Acad Neurol. 2010 Jul;13(3):233. doi: 10.4103/0972-2327.70888.
本文引用的文献
1
Perioperative management of antiplatelet agents in noncardiac surgery.非心脏手术中抗血小板药物的围手术期管理
Eur J Anaesthesiol. 2009 Mar;26(3):181-7. doi: 10.1097/eja.0b013e328324b79f.
2
The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry.埃森中风风险评分可预测心血管事件复发：在持续健康动脉粥样硬化血栓形成减少（REACH）注册研究中的验证。
Stroke. 2009 Feb;40(2):350-4. doi: 10.1161/STROKEAHA.108.521419. Epub 2008 Nov 20.
3
Antiplatelet drugs in cardiological practice: established strategies and new developments.心脏病学实践中的抗血小板药物：既定策略与新进展
Vasc Health Risk Manag. 2008;4(3):637-45. doi: 10.2147/vhrm.s2691.
4
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.在有效避免二次中风预防方案（PRoFESS）试验中，阿司匹林加缓释双嘧达莫与氯吡格雷及替米沙坦对缺血性中风患者复发性中风后残疾和认知功能的影响：一项双盲、活性药物与安慰剂对照研究。
Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29.
5
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).缺血性卒中的抗栓与溶栓治疗：美国胸科医师学会循证临床实践指南（第8版）
Chest. 2008 Jun;133(6 Suppl):630S-669S. doi: 10.1378/chest.08-0720.
6
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.西洛他唑作为缺血性中风后阿司匹林的替代药物：一项随机、双盲、试点研究。
Lancet Neurol. 2008 Jun;7(6):494-9. doi: 10.1016/S1474-4422(08)70094-2. Epub 2008 May 2.
7
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.美国心脏协会/美国卒中协会关于卒中及短暂性脑缺血发作患者卒中预防建议的更新
Stroke. 2008 May;39(5):1647-52. doi: 10.1161/STROKEAHA.107.189063. Epub 2008 Mar 5.
8
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2008年心脏病和中风统计数据更新：美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2008 Jan 29;117(4):e25-146. doi: 10.1161/CIRCULATIONAHA.107.187998. Epub 2007 Dec 17.
9
Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare population.急性缺血性卒中住院后的再入院及死亡情况：医疗保险人群的5年随访
Stroke. 2007 Jun;38(6):1899-904. doi: 10.1161/STROKEAHA.106.481465. Epub 2007 May 17.
10
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.动脉源性脑缺血后中等强度口服抗凝剂与阿司匹林对比研究（ESPRIT）：一项随机对照试验
Lancet Neurol. 2007 Feb;6(2):115-24. doi: 10.1016/S1474-4422(06)70685-8.
Zotero 插件